Back to Journals » Drug Design, Development and Therapy » Volume 15

Sulfasalazine Inhibits Inflammation and Fibrogenesis in Pancreas via NF-κB Signaling Pathway in Rats with Oxidative Stress-Induced Pancreatic Injury [Corrigendum]

Authors Wang Y, Tian F, Yan M, Fan J, Wang L, Kuang R, Li Y

Received 11 June 2021

Accepted for publication 11 June 2021

Published 16 June 2021 Volume 2021:15 Pages 2563—2564


Wang Y, Tian F, Yan M, et al. Drug Des Dev Ther. 2016;10:1743–1751.


The authors have advised Figure 1A on page 1746 is incorrect. The authors inadvertently chose b and c from the same group of candidate representative images during figure assembly. The correct Figure 1 is shown below.


The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.